| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/20/2006 | CN1275977C O-aryl glucoside SGL T2 inhibitors |
| 09/20/2006 | CN1275969C Application of active ingredient of coumarin category distilled from dahurian angelica in preparing medicine for curing high blood pressure and its extracting method |
| 09/20/2006 | CN1275967C Benzensulfonic acid indol-5-yl esters and antigonists of the 5-HT6 receptor |
| 09/20/2006 | CN1275962C Novel anticholinergic agents that can be used as medicaments and method for the production thereof |
| 09/20/2006 | CN1275958C Genistein-3'-sodium sulfonate, dimethylation daidzein-3'-sodium sulfonate, their preparing process and pharmaceutical use |
| 09/20/2006 | CN1275940C New phenylalkyloxy-phenyl derivatives |
| 09/20/2006 | CN1275938C Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 09/20/2006 | CN1275647C Application of neutral proteinase in preparing medicine for anorectal diseases and the medicine |
| 09/20/2006 | CN1275634C Health tea capable of reducing blood lipid, blood viscosity and blood pressure |
| 09/20/2006 | CN1275627C Medicine for treating insufficiency of the kidney-yang syndrome and its preparing method |
| 09/20/2006 | CN1275622C Chinese traditional medicine preparation for treating coronary heart disease and angina pectoris and preparation method thereof |
| 09/20/2006 | CN1275619C Chinese medicine composition for treating ischemic apoplexy and its preparing method |
| 09/20/2006 | CN1275615C Levulose absorption retardant, compound, food and levulose absorption repressor |
| 09/20/2006 | CN1275614C Medicinal composition for apoplexy and its sequel and its preparation |
| 09/20/2006 | CN1275609C Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 09/20/2006 | CN1275606C Medical usage of simonder wood oil |
| 09/20/2006 | CN1275599C Cyclophosphadenosine glucosamine infusion prepn., and its prepn. process |
| 09/20/2006 | CN1275597C System with extensible released drug containing extract of hawkthom leaves |
| 09/20/2006 | CN1275596C Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |
| 09/20/2006 | CN1275594C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/20/2006 | CN1275591C Traditional Chinese medicine slow-releasing medicine for treating cardiovascular disease and its preparation method |
| 09/20/2006 | CN1275590C Dispersion tablet containing ginkgo leaf extract and preparation method thereof |
| 09/19/2006 | US7109361 Isolation of lutein from alfalfa |
| 09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/19/2006 | US7109342 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 09/19/2006 | US7109333 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects |
| 09/19/2006 | US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems |
| 09/19/2006 | US7109234 Benzoxathiepine derivatives and their use as medicines |
| 09/19/2006 | US7109226 PPAR-activating compound and pharmaceutical composition comprising the compound |
| 09/19/2006 | US7109222 Thiazole or oxazole derivatives such as 5-(4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl)-indan-2-carboxylic acid; Hypercholesterolemia, hyperlipidemia, and diabetes |
| 09/19/2006 | US7109219 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 09/19/2006 | US7109218 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/19/2006 | US7109207 Used to treat metabolic disorders, eating disorders such as hyperphagia, and diabetes |
| 09/19/2006 | US7109205 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 09/19/2006 | US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 09/19/2006 | US7109199 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 09/19/2006 | US7109198 Method for treating obesity |
| 09/19/2006 | US7109196 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 09/19/2006 | US7109194 3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use |
| 09/19/2006 | US7109191 for inhibiting bone resorption, restenosis, atherosclerosis, inflammatory arthritis, diabetic retinopathy, macular degeneration, angiogenesis, cancer |
| 09/19/2006 | US7109189 Mitochondrially targeted antioxidants |
| 09/19/2006 | US7109180 Stimulate mammalian coronary vasodilatation, imaging the heart |
| 09/19/2006 | US7109176 For therapy of inflammatory diseases and conditions in humans and animals |
| 09/19/2006 | US7109164 Administering compounds such as 3-[[3,5-dibromo-[4-hydroxy-3-(1-methylethyl)phenoxy]-phenyl]amino]-3-oxopropanoic acid for therapy of obesity, hypercolesterolemia atherosclerosis, depression, osteoporosis, hypothyroidism, goiter, glaucoma, cardiac arrhythmia, congestive heart failure, or a skin disorder |
| 09/19/2006 | US7108866 Chronotherapeutic diltiazem formulations and the administration thereof |
| 09/19/2006 | CA2232195C Isoxazolidine derivatives |
| 09/19/2006 | CA2154601C Formulations containing coumarins and the use thereof in the pharmaceutical and cosmetic fields |
| 09/19/2006 | CA2140989C Phenyl-substituted alkylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnosticagent, and a medicament containing them |
| 09/18/2006 | CA2501253A1 Means and methods for individualized drug therapy and for predicting adverse drug reaction |
| 09/14/2006 | WO2006096358A1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists |
| 09/14/2006 | WO2006096030A1 Potassium channel opener having benzofuroindole skeleton |
| 09/14/2006 | WO2006095922A1 Tetrahydroisoquinoline compound and medicinal use thereof |
| 09/14/2006 | WO2006095897A1 Screening method |
| 09/14/2006 | WO2006095844A1 Pharmaceutical preparation |
| 09/14/2006 | WO2006095822A1 Sulfonamide compound and pharmaceutical thereof |
| 09/14/2006 | WO2006095713A1 Inhibitor of plasminogen activator inhibitor-1 |
| 09/14/2006 | WO2006095711A1 Method of regenerating or repairing damaged tissue by using adrenomedulin |
| 09/14/2006 | WO2006095675A1 Anti-atherogenic composition |
| 09/14/2006 | WO2006095666A1 Pyrazolopyridine-4-yl pyridazinone derivative and addition salt thereof, and pde inhibitor comprising the derivative or salt as active ingredient |
| 09/14/2006 | WO2006095636A1 Novel compound selectively activated at target site and utilization of the same |
| 09/14/2006 | WO2006095357A1 A synergistically heat stable oil media having eicosa pentaenoic acid (epa) and docosa hexaenoic acid (dha) |
| 09/14/2006 | WO2006094764A1 Formulation for aviptadil |
| 09/14/2006 | WO2006094763A1 3,4,5-substituted piperidine compounds |
| 09/14/2006 | WO2006094703A1 Use of an antagonist of epac for treating human cardiac hypertrophy |
| 09/14/2006 | WO2006094536A1 Targeted plasminogen activator fusion proteins as thrombolytic agents |
| 09/14/2006 | WO2006094451A1 The use of hydrochloric acid for the manufacture of a medicament for the treatment of hypertension |
| 09/14/2006 | WO2006094357A1 Flavonoid compounds and uses thereof |
| 09/14/2006 | WO2006053161A8 Use ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure |
| 09/14/2006 | WO2006010568A3 Substituted pyrido[3',2':4,5]thieno[3,2-d]pyrimidine-2,4(1 h,3h)-diones and -4(3h)-ones, pyrido[3',2':4,5]furo[3,2-d]pyrimidine-2,4(1 h,3h)-diones and -4(3h)-ones, and use thereof as inhibitors of tnf-alpha release |
| 09/14/2006 | WO2006009465A3 Composition comprising protein material and non-oxidizable fatty acid entities |
| 09/14/2006 | US20060205951 New crystal modification of torasemide |
| 09/14/2006 | US20060205814 Administering mixture of eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester; cardiovascular disorders; administered along with ACE-, NEP-, or phosphodiesterase inhibitors; diuretics, positive inotropic drugs, vasodilators, beta-blockers, digitalis glycosides |
| 09/14/2006 | US20060205812 5-Amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 09/14/2006 | US20060205801 Crystal and process for producing the same |
| 09/14/2006 | US20060205763 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205762 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205750 Cardiovascular disorders; central nervous system disorders; metabolic diseases; therapy for eating disorders; trans-2-(2-fluorophenyl)-8-[3'-oxospiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-yl]purine |
| 09/14/2006 | US20060205734 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/14/2006 | US20060205726 e.g. 2-(2-{3-acetoxy-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetoxymethyl)-2-phenylmalonic acid diethyl ester; microsomal triglyceride transfer protein inhibitor in small intestine; antihyperlipidemic, antidiabetic agent; arteriosclerosis, coronary artery diseases, obesity |
| 09/14/2006 | US20060205723 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/14/2006 | US20060205722 Such as N-{1-[2-(1,3-dioxan-2-yl)ethyl]piperidin-4-yl}-N-(4-fluorobenzyl)-2-[4-(2-hydroxy-2-methylpropoxy)phenyl]acetamide; selective inverse agonists of 5-HT2A receptor with minimal monamine receptors subtype activity; antipsychotics with reduced side effects |
| 09/14/2006 | US20060205712 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 09/14/2006 | US20060205710 Spiroazacyclic compounds as monoamine receptor modulators |
| 09/14/2006 | US20060205709 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 09/14/2006 | US20060205708 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/14/2006 | US20060205695 4,4'-dithiobis-(3,3'-amino-6,6'-phenyl-1,1'-hexanesulfonic) acid; hypotensive agents for cardiovascular disorders, arterial hypertension, cardiac insufficiency and renal failure, myocardial infarction diabetic proteinuria |
| 09/14/2006 | US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 09/14/2006 | US20060205665 Non-basic amino acid sequence transporter peptide conjugated to biological effector; translocation across the membrane of eukaryotic cells |
| 09/14/2006 | US20060205659 Peptide radical having 5-25 amino acids with its N-terminus capped with a monoester of fumaric acid; used to treat autoimmune diseases, mitochondrial diseases, and NF-kappaB mediated diseases and in transplantation medicine |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205074 Neural progenitor cells derived from whole bone marrow |
| 09/14/2006 | US20060205021 Mammalian IAP gene family, primers, probes and detection methods |
| 09/14/2006 | US20060205018 Polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides; use in therapy |
| 09/14/2006 | US20060204591 Treatment of mucosal membranes |
| 09/14/2006 | US20060204489 Protein C derivatives |
| 09/14/2006 | US20060204449 Nasal pharmaceutical composition of piribedil |
| 09/14/2006 | CA2601985A1 A synergistically heat stable oil media having eicosa pentaenoic acid (epa) and do-cosa hexaenoic acid (dha) |
| 09/14/2006 | CA2601279A1 Formulation for aviptadil |
| 09/14/2006 | CA2601271A1 Targeted plasminogen activator fusion proteins as thrombolytic agents |
| 09/14/2006 | CA2601028A1 Flavonoid compounds and uses thereof |